Combination inhibition activity of chlorhexidine and antibiotics on multidrug-resistant Acinetobacter baumannii in vitro

Chlorhexidine is a bisbiguanide antiseptic, disinfectant and preservative that is effective against a wide range of bacteria, and also a broad-spectrum antimicrobial agent that is active against aerobic and anaerobic bacteria [1, 2]. It is widely used in children and adults with an excellent record of safety and efficacy for applications as diverse as hand washing, preoperative skin preparation, vaginal antisepsis, treatment of gingivitis, and body washes to prevent neonatal sepsis [3‐5]. Chlorhexidine acts primarily on the bacterial cell membrane causing leakage of intracellular material. Low concentrations of chlorhexidine affect membrane integrity, whereas high concentrations cause congealing of the cytoplasm [2]. One research has shown that chlorhexidine can decrease the mortality and infection rate in the hospital setting, especially in the intensive care unit [3]. However, other researches have also found that several bacteria, including A. baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, have reduced susceptibility or are resistant to chlorhexidine [6‐8].

A. baumannii is an opportunistic nosocomial pathogen which can survive for prolonged periods in the hospital environment. A. baumannii causes infections including bacteremia, pneumonia, meningitis, septicemia, urinary tract infections, wound and skin infections [9, 10]. The multidrug-resistant (MDR) and extremely-drug resistant (XDR), even the pan-drug resistant (PDR) A. baumannii have been found in hospitals. The carbapenem-resistant A. baumannii was identified as a priority by the World Health Organization’s (WHO) report on pathogens requiring research and development of new antibiotics. An important technique to prevent and control the spread of A. baumannii infection in the hospital setting is to remove the bacterial cell from the surface of medical devices. In recent years, research has focused on the antimicrobial resistance and reduced biocide susceptibility of A. baumannii [10‐12]. The chlorhexidine non- susceptibility A. baumannii in clinical isolates has been described previously [11]. In addition, chlorhexidine bathing significantly reduces colonization of A. baumannii in intensive care unit settings [13]. Özçaka Ö et al [14] found chlorhexidine decreases the risk of ventilator-associated pneumonia in intensive care unit patients, and A. baumannii was the most common pathogen (64.7%, 27/34) of all species identified. However, whether bathing can reduce A. baumannii infections requires validation with further studies. Therefore, this study aimed to test chlorhexidine combined with antibiotics against the MDR and XDR A. baumannii isolated from clinical departments.

A. baumannii has become a major threat in the hospital environment by causing nosocomial infections and colonization. It is inherently resistant to multiple antibiotics [10, 17]. In the present study, MDR, XDR, PDR and biocides non-susceptible A. baumannii were isolated from clinical patients [11]. A. baumannii clinical isolates have been isolated from sputum samples which frequently lead to pneumonia. In a previous study, the sputum samples accounted for 89.36% of the total samples [11]. Chlorhexidine has good bactericidal effect and high safety on many bacteria. Some clinical research found chlorhexidine decreases the risk of pneumonia by maintaining good oral hygiene and body washing [14, 18] . A recent study has shown that chlorhexidine could reduce the susceptibility to A. baumannii infection [11].

Other studies have also shown that chlorhexidine alone or in combination with other antibiotics can prevent and reduce hospital-acquired infections, including respiratory catheter, gastric tube and urinary catheter [13, 19‐21]. For example, Jamal et al. [21] showed chlorhexidine alone, or combine with minocycline and rifampicin, reduced the incidence of A. baumannii catheter-related infections. In this study, chlorhexidine combinations with doxycycline, minocycline, levofloxacin, ciprofloxacin, imipenem, or meropenem against 6 MDR and 24 XDR A. baumannii clinical isolates were tested in vitro. The results showed chlorhexidine combinations with DOX, MIN, MER, or CIP were synergistic in all biocide combinations, with more than 50% of isolates showing FICI ≤0.5. Additionally, the chlorhexidine and antimicrobial MIC values were decreased, which indicates that this technique could effectively reduce drug resistance. However, methods for implementation in clinical settings which avoid adverse drug reactions need to be elucidated. The biocides combined with antibiotics can be used in clinical isolate inhabitation. Since chlorhexidine can be used on the body surface, it can be mixed with antibacterial drugs for disinfectant wipes used in patients’ oral care, tracheal intubation and ventilators, to eliminate fixed-value bacteria and prevent the spread of infection.

The solution of IMP in normal saline solution was stable 3 to 4 h stored at 25 °C [22]. MER in 0.9% saline was stable at least 7 h if the temperature does not increase to 22 °C, while MER stability at 5 h when temperature does not exceed 33 °C [23]. Chlorhexidine combination with MER shown synergistic effects than IMP, and chlorhexidine together with IMP was indifferent in 10% of isolates. Cause IMP easy to lost activity when under test temperature. Meanwhile, solution of CIP was diluted in 0.9% sodium chloride, and the solution was stale at least 3 months when stored at room temperatures [24]. LEV was stable in 0.9% sodium chloride when stored at 25 °C for 3 days [25]. The MIN diluted in Mueller-Hinton agar plate was instable when stored under refrigeration, and DOX also lost activity at a slower rate [26]. The LEV, CIP, DOX and MIN are stable when under test temperature. The combinations of chlorhexidine with DOX and MIN as well as LEV and CIP had the same effects in all test isolates.

In conclusion, Chlorhexidine combined with antibacterial drugs has synergistic or additive antibacterial effects against multiple and pan-resistant A. baumannii. This new technique may have important implications for the treatment and transmission control of A. baumannii infection.